Kids Library Home

Welcome to the Kids' Library!

Search for books, movies, music, magazines, and more.

Extended Display Limit/Sort Search
     
Available items only
Result Page   
Add Marked to Bag Add All On Page
Num Mark Titles (51-100 of 337) Year Entries
371 Found
51 Guidance for industry [electronic resource] : bioavailability and bioequivalence studies for nasal a   2003 1
52 Guidance for industry [electronic resource] : biological product deviation reporting for blood and p   2006 1
53 Guidance for industry [electronic resource] : biological product deviation reporting for licensed ma   2008 1
54 Guidance for industry [electronic resource] : blood establishment computer system validation in the   2007 1
55 Guidance for industry [electronic resource] : botanical drug products.   2004 1
56 Guidance for industry [electronic resource] : brief summary : disclosing risk information in consume   2004 1
57 Guidance for industry [electronic resource] : carcinogenicity study protocol submissions.   2002 1
58 Guidance for industry [electronic resource] : cell selection devices for point of care production of   2007 1
59 Guidance for industry [electronic resource] : certain human cells, tissues and cellular and tissue-b   2008 1
60 Guidance for industry [electronic resource] : CGMP for phase 1 investigational drugs.   2008 1
61 Guidance for industry [electronic resource] : changes to an approved application : biological produc   2001 1
62 Guidance for industry [electronic resource] : changes to an approved NDA or ANDA.   2004 1
63 Guidance for industry [electronic resource] : changes to an approved NDA or ANDA, questions and answ   2001 1
64 Guidance for industry [electronic resource] : changes to an approved NDA or ANDA, specifications, us   2004 1
65 Guidance for industry [electronic resource] : characterization and qualification of cell substrates   2006 1
66 Guidance for industry [electronic resource] : class II special controls guidance document : cord blo   2007 1
67 Guidance for industry [electronic resource] : class II special controls guidance document : in vitro   2007 1
68 Guidance for industry [electronic resource] : classifying resubmissions in response to action letter   1998 1
69 Guidance for industry [electronic resource] : clinical data needed to support the licensure of pande   2007 1
70 Guidance for industry [electronic resource] : clinical data needed to support the licensure of seaso   2007 1
71 Guidance for industry [electronic resource] : clinical lactation studies; study design, data ana   2005 1
72 Guidance for industry [electronic resource] : clinical pharmacology section of labeling for human pr   2009 1
73 Guidance for industry [electronic resource] : clinical studies section of labeling for human prescri   2006 1
74 Guidance for industry [electronic resource] : clozapine tables, in vivo bioequivalence and in vitro   2005 1
75 Guidance for industry [electronic resource] : collection of race and ethnicity data in clinical tria   2005 1
76 Guidance for industry [electronic resource] : comparability protocols, protein drug products and bio   2003 1
77 Guidance for industry [electronic resource] : compliance with 21 CFR part 1271.150(c)(1), manufactur   2006 1
78 Guidance for industry [electronic resource] : "computer crossmatch" (electronic based testin   2007 1
79 Guidance for industry [electronic resource] : computerized systems used in clinical investigations.   2007 1
80 Guidance for industry [electronic resource] : computerized systems used in clinical trials.   1999 1
81 Guidance for industry [electronic resource] : considerations for allogeneic pancreatic islet cell pr   2008 1
82 Guidance for industry [electronic resource] : considerations for developmental toxicity studies for   2
83 Guidance for industry [electronic resource] : considerations for plasmid DNA vaccines for infectious   2007 1
84 Guidance for industry [electronic resource] : consumer-directed broadcast advertisements.   1999 1
85 Guidance for industry [electronic resource] : consumer-directed broadcast advertisements, questions   1999 1
86 Guidance for industry [electronic resource] : container and closure system integrity testing in lieu   2008 1
87 Guidance for industry [electronic resource] : container closure systems for packaging human drugs an   1999 1
88 Guidance for industry [electronic resource] : container closure systems for packaging human drugs an   2002 1
89 Guidance for industry [electronic resource] : content and format for geriatric labeling.   2001 1
90 Guidance for industry [electronic resource] : content and format of investigational new drug applica   1995 1
91 Guidance for industry [electronic resource] : contents of a complete submission for the evaluation o   2008 1
92 Guidance for industry [electronic resource] : cooperative manufacturing arrangements for licensed bi   2008 1
93 Guidance for industry [electronic resource] : court decisions, ANDA approvals, and 180-day exclusivi   2000 1
94 Guidance for industry [electronic resource] : criteria for safety and efficacy evaluation of oxygen   2004 1
95 Guidance for industry [electronic resource] : Current Good Tissue Practice (CGTP) and additional req   2009 1
96 Guidance for industry [electronic resource] : development and use of risk minimization action plans.   2005 1
97 Guidance for industry [electronic resource] : dissolution testing of immediate release solid oral do   1997 1
98 Guidance for industry [electronic resource] : drug-induced liver injury, premarketing clinical evalu   2
99 Guidance for industry [electronic resource] : drug master files for bulk antibiotic drug substances.   1999 1
100 Guidance for industry [electronic resource] : E 10 choice of control group and related issues in cli   2
Add Marked to Bag Add All On Page
Locate in results
Result Page   
Extended Display Limit/Sort Search
 
    
Available items only